Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Topography-Guided Custom Ablation Not as Accurate as Wavefront-Optimized Ablation
  • Refractive Surgery/Vision Correction

Topography-Guided Custom Ablation Not as Accurate as Wavefront-Optimized Ablation

Ophthalmology 360
Topography-Guided Custom Ablation Not as Accurate as Wavefront-Optimized Ablation

Topography-guided custom ablation in virgin eyes induced less corneal optical path difference, higher-order aberrations, and coma, but was not as accurate as wavefront-optimized ablation, according to a new study in the Journal of Refractive Surgery. Specifically, the study examined outcomes between topography-guided customized ablation treatment (TCAT) and wavefront-optimized (WFO) LASIK in myopic patients.

The prospective randomized contralateral study included 432 eyes of 216 myopic patients who underwent LASIK. TCAT was randomly performed in one eye and WFO LASIK in the other. The WaveLight FS200 femtosecond laser (Alcon Laboratories, Inc., Fort Worth, TX) was used to create the flap and the EX500 excimer laser was used for photoablation. Refractive and visual outcomes and corneal aberrations were compared between groups.

At 1-month follow-up, uncorrected distance visual acuity was 20/20 or better in 89.4% of eyes in the TCAT group and 93.5% of eyes in the WFO group (P < .05). Corrected distance visual acuity and residual manifest refractive spherical equivalent were similar between groups (P > .05). The optical path difference and root mean square of higher-order aberrations and coma were significantly lower in eyes in the TCAT group at 1- and 6-month follow-up (P < .05).

Ultimately, TCAT was not as accurate as WFO LASIK.

Reference:

Zhang Y, Chen Y. A randomized comparative study of topography-guided versus wavefront-optimized fs-lasik for correcting myopia and myopic astigmatism. J Refract Surg. 2019;35(9):575–582. doi: 10.3928/1081597X-20190819-01.

Share

Related Content

  • Refractive Surgery/Vision Correction

First-in-human study underway for non-invasive vision correction technology

  • Refractive Surgery/Vision Correction

Tips to successfully integrate EVO ICL into office-based surgery

Dr. Ling implanting EVO ICL
  • Refractive Surgery/Vision Correction

EVO ICL plays a strategic role in my refractive business model

  • Cornea and External Disease

Who is the ideal candidate for EVO ICL?

  • Cornea and External Disease

Impact of corneal size on refractive surgery outcomes highlighted in new research

  • Refractive Surgery/Vision Correction

As a lower-viscosity topical anesthetic, IHEEZO™ poses no barrier to antisepsis

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon